Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

about

Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy.

P2860

Q41706903-9D33F577-903F-4F94-806F-5937C507297E

P2860

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

Item

http://www.wikidata.org/entity/Q50485231

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Dosimetric assessment of prost ...... ipal component analysis (PCA).

@en

Dosimetric assessment of prostate cancer patients through principal component analysis

@nl

type

Item

label

Dosimetric assessment of prost ...... ipal component analysis (PCA).

@en

Dosimetric assessment of prostate cancer patients through principal component analysis

@nl

prefLabel

Dosimetric assessment of prost ...... ipal component analysis (PCA).

@en

Dosimetric assessment of prostate cancer patients through principal component analysis

@nl

P1476

Dosimetric assessment of prost ...... ipal component analysis (PCA).

@en

P2093

Aime M Gloi

http://www.w3.org/2001/XMLSchema#string

Robert Buchanan

http://www.w3.org/2001/XMLSchema#string

P2860

Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.

Fitting of normal tissue tolerance data to an analytic function.

Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data

Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.

Is alpha/beta for prostate tumors really low?

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Epidemiology of prostate cancer.

Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Reporting and analyzing dose distributions: a concept of equivalent uniform dose.

P304

3882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1120/JACMP.V14I1.3882

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23318379

http://www.w3.org/2001/XMLSchema#string

P921

principal component analysis

P932

5713663

http://www.w3.org/2001/XMLSchema#string

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

about

P2860

P2860

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932